Skip to content
Saturday, June 21, 2025
Latest:
  • From the classroom to the capitol: Medical students in action
  • Study reveals heterogeneity of bone metastases across different and same cancer types
  • What is testosterone therapy?
  • New lungs give Gabriel Chavez a fresh start
  • Researchers identified new indicators for HER2+ breast cancer response to therapy
Baylor College of Medicine Blog Network

  • Home
  • Momentum
    • About Momentum
    • Resources
    • Contributors
      • Taylor Barnes
      • Dana Benson
      • Molly Chiu
      • Julie Garcia
      • Graciela Gutierrez
      • Anna Kiappes
      • Andy Phifer
      • Homa Shalchi
      • Melissa Tucker
    • Contact Us
  • From The Labs
    • About From the Labs
    • Follow From The Labs on Twitter
  • Policywise
    • About PolicyWise
    • Follow @BCMEthics on Twitter
  • The Stitch
    • About The Stitch
  • Progress Notes
    • About Progress Notes
    • Progress Notes Editors
    • Connect With Us
  • bcm.edu
A Band-Aid being applied to a child's arm after they were given a vaccine.
From The Labs

It’s a first: implementing safe and effective RSV prevention treatments significantly reduces hospitalizations in infants

June 10, 2025 children diseases,  hospitalization,  maternal RSV vaccine,  prevention,  public health,  RSV,  RSV monoclonal antibodies,  timely vaccination

Respiratory syncytial virus (RSV) is the number one cause of hospitalization in infants, accounting for about 25% of all their hospitalizations.

Read More
Policywise

Protecting your baby from RSV: What every parent needs to know

September 27, 2024 immunization,  infant,  mother,  pediatrics,  Pregnancy,  Respiratory syncytial virus,  RSV,  vaccine

Having a sick baby can be a parent’s nightmare. Imagine your baby has been sick for a few days, and the pediatrician tells you it’s

Read More
A young person about to get a shot in their arm
Policywise

Unlocking the Secrets of Maternal RSV Immunization: What Every Parent Should Know

November 10, 2023 Abrysvo,  maternal health,  maternal immunization,  Pfizer’s bivalent RSVpreF (Abrysvo),  pregnant,  Respiratory Syncytial Virus (RSV),  RSV

On  May 18, 2023, the FDA voted to approve Pfizer’s bivalent RSVpreF (Abrysvo) vaccine for pregnant women to protect their newborns against respiratory syncytial virus

Read More
From The Labs

Miniature model of the human nose reveals early events of SARS-CoV-2 and RSV infection

February 22, 2022 COVID-19,  human nose model,  human nose organoid,  palivizumab,  Research,  RSV,  SARS-CoV-2

Researchers anticipate that the human nose organoid system would help accelerate the transfer of lab-developed therapeutics to the bedside.

Read More
From The Labs

Antibody response and ‘original antigenic sin’ in RSV influence vaccine development

February 11, 2021 COVID-19,  immunity to RSV,  Research,  RSV,  RSV antibodies,  vaccine development

Variation of human immune response to RSV reinfection suggests it is important to consider this variation in vaccine design.

Read More

From the Labs: Image of the Month

Blood vessels (magenta) intertwined with metastatic medulloblastoma tumor cells (green) nestled within the protective layers that surround the mouse spinal cord. From the Labs: a closer look at metastatic medulloblastoma

Healthy Habits: A DOC-umentary Series

https://www.youtube.com/watch?v=SlNiMWHUhbc

Archives

Search

©1998 - 2023 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951